Literature DB >> 18264022

Risk factors for febrile morbidity after abdominal hysterectomy in a university hospital in Thailand.

Watcharin Chirdchim1, Jitti Hanprasertpong, Visit Prasartwanakit, Alan Geater.   

Abstract

AIM: To identify the risk factors for febrile morbidity after hysterectomy.
METHODS: This was a historical cohort study of 1,980 women who had undergone hysterectomy between October 1998 and December 2005. Multiple logistic regression was used to identify risk factors for febrile morbidity.
RESULTS: Among the cohort, 1,463 women were nonfebrile and 517 febrile--an incidence of febrile morbidity of 26.1%. The incidence of febrile morbidity was higher in patients with lower preoperative hematocrit, more extensive surgery, longer operative time, greater blood loss and malignant disease. The median intraoperative blood loss was 500 ml in the febrile group and 400 ml in the non-febrile group (p < 0.0005). Median operative time was 150 min in the febrile group and 135 min in the non-febrile group (p < 0.0005). Two variables were identified as independent risk factors for febrile morbidity: intraoperative blood loss of > or =750 ml (compared with <250 ml OR 1.52; 95% CI 1.08-2.13; p = 0.036) and a diagnosis of malignant disease (OR 1.86; 95% CI 1.45-2.13; p < 0.0005).
CONCLUSIONS: Independent risk factors for febrile morbidity were an intraoperative blood loss of > or =750 ml and malignant disease. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18264022     DOI: 10.1159/000115843

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  2 in total

1.  Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Authors:  Meir Mizrahi; Lilach Roemi; Daniel Shouval; Tomer Adar; Maya Korem; Alon Moses; Alan Bloom; Oren Shibolet
Journal:  World J Hepatol       Date:  2011-05-27

2.  Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer.

Authors:  Ingporn Jiamset; Jitti Hanprasertpong
Journal:  J Gynecol Oncol       Date:  2016-05       Impact factor: 4.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.